Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Jan;22(1):e00504.
doi: 10.1016/j.neurot.2024.e00504. Epub 2024 Dec 19.

Metabolomic and lipidomic pathways in aneurysmal subarachnoid hemorrhage

Affiliations
Review

Metabolomic and lipidomic pathways in aneurysmal subarachnoid hemorrhage

Bosco Seong Kyu Yang et al. Neurotherapeutics. 2025 Jan.

Abstract

Aneurysmal subarachnoid hemorrhage (aSAH) results in a complex systemic response that is critical to the pathophysiology of late complications and has important effects on outcomes. Omics techniques have expanded our investigational scope and depth into this phenomenon. In particular, metabolomics-the study of small molecules, such as blood products, carbohydrates, amino acids, and lipids-can provide a snapshot of dynamic subcellular processes and thus broaden our understanding of molecular-level pathologic changes that lead to the systemic response after aSAH. Lipids are especially important due to their abundance in the circulating blood and numerous physiological roles. They are comprised of a wide variety of subspecies and are critical for cellular energy metabolism, the integrity of the blood-brain barrier, the formation of cell membranes, and intercellular signaling including neuroinflammation and ferroptosis. In this review, metabolomic and lipidomic pathways associated with aSAH are summarized, centering on key metabolites from each metabolomic domain.

Keywords: Aneurysmal subarachnoid hemorrhage; Lipidome; Metabolome.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest AMG received support from the NINDS (K23NS121628). HAC received support from the NINDS (R01NS131469, R61NS119640).

Figures

Fig. 1
Fig. 1
Major lipid metabolites involved in the secondary injury from subarachnoid hemorrhage.
Fig. 2
Fig. 2
Plasma-free fatty acid levels (FFA) after various forms of acute brain injury. Plasma samples were collected from subjects within 24 ​h of either traumatic brain injury (TBI), aneurysmal subarachnoid hemorrhage (aSAH), or intracerebral hemorrhage (ICH). Control subjects were recruited from an outpatient clinic during a visit for routine health maintenance. Total FFA levels were detected using a fluorometric assay kit (Cayman Chemical). ∗p ​< ​0.01.

References

    1. le Roux AA, Wallace MC. Outcome and cost of aneurysmal subarachnoid hemorrhage. Neurosurg Clin N Am. 2010 Apr;21(2):235–246. doi: 10.1016/j.nec.2009.10.014. PMID: 20380966. - DOI - PubMed
    1. English S.W. Long-term outcome and economic burden of aneurysmal subarachnoid hemorrhage: are we only seeing the tip of the iceberg? Neurocrit Care. Springer. 2020:37–38. - PubMed
    1. Etminan N., Chang H.-S., Hackenberg K., De Rooij N., Vergouwen M., Rinkel G., et al. Worldwide incidence of aneurysmal subarachnoid hemorrhage according to region, time period, blood pressure, and smoking prevalence in the population. JAMA Neurol. 2019;76(5):588. - PMC - PubMed
    1. Modi S., Shah K., Schultz L., Tahir R., Affan M., Varelas P. Cost of hospitalization for aneurysmal subarachnoid hemorrhage in the United States. Clin Neurol Neurosurg. 2019;182:167–170. - PubMed
    1. Vergouwen M.D.I., Vermeulen M., van Gijn J., Rinkel G., Wijdicks E., Muizelaar J.P., et al. Definition of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as an outcome event in clinical trials and observational studies. Stroke. 2010;41(10):2391–2395. - PubMed

LinkOut - more resources